Xiaoran Ding

Title: Innovator Xiaoran Ding: Pioneering Advances in Biotechnology

Introduction

Xiaoran Ding, an accomplished inventor based in Zhejiang, China, has made significant contributions to the field of biotechnology with a focus on innovative therapeutics. With a total of four patents to his name, Ding's work showcases the intersection of molecular biology and medical applications, promising new approaches to treating cancer and other diseases.

Latest Patents

Ding's latest patents highlight his groundbreaking research in fusion proteins and antibody technologies. One notable patent, titled "Fusion protein and use thereof," describes a fusion protein that combines a first binding domain targeting tumor-associated antigens with a second binding domain that specifically binds CD47 proteins. This innovation includes an array of components such as immunoconjugates, nucleic acid molecules, and vectors that are essential for developing effective medicaments.

Another significant patent, "Antibody binding to AXL protein and application thereof," presents an antibody capable of binding to the AXL protein with high specificity. This antibody not only recognizes AXL on cell surfaces but also facilitates internalization, potentially leading to the inhibition of tumor cell proliferation. This research opens up new avenues for cancer immunotherapy.

Career Highlights

Throughout his career, Xiaoran Ding has worked with prominent organizations such as Hangzhou Sumgen Biotech Co., Ltd. and Sumgen Mab (Beijing) Biotech Co., Ltd. His experience in these companies has allowed him to develop and refine his cutting-edge inventions while contributing to the biotechnology landscape.

Collaborations

Ding has collaborated with esteemed colleagues, including Ming Lv and Shiwei Miao, who have been instrumental in advancing his projects. Their combined expertise underscores the importance of teamwork in driving innovation within the scientific community.

Conclusion

Xiaoran Ding's impressive portfolio of patents and his dedication to advancing biotechnological innovations position him as a leading figure in the development of novel therapeutic strategies. As he continues to push the boundaries of science, his work holds promise for transformative impacts in medicine, particularly in the fight against cancer.